低剂量透皮丸激素治疗改善了患有慢性稳定性胸痛的男性的胸痛值:一项随机,双盲,安慰剂控制的随机研究
K M English1, R P Steeds, T H Jones
1Department of Cardiology, Royal Hallamshire Hospital, Sheffield, UK.
Circulation
|October 18, 2000
概括
在患有胸痛的男性中,低剂量丸激素治疗改善了运动能力,并减少了胸痛. 这项试点研究表明,丸激素可能是慢性稳定性胸痛的可行治疗方法.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 实验研究表明,雄激素促进冠状动脉血管扩张.
- 这项试点研究调查了长期,低剂量雄激素在男性胸痛患者的临床影响.
研究的目的:
- 评估低剂量丸激素补充剂在患有慢性稳定性胸痛的男性中的疗效.
- 评估丸激素对这个患者群体的运动耐受性和生活质量的影响.
主要方法:
- 这是一项为期12周的双盲,安慰剂对照试验,涉及46名患有稳定性胸痛的男性.
- 参与者每天接受5毫克的透皮或安慰剂,同时服用现有的药物.
- 测量包括ST段抑郁的时间,激素水平和SF-36生活质量得分.
主要成果:
- 在运动测试中,丸激素治疗显著增加了雄激素水平,并延长了ST段抑郁的时间 (P=0.02).
- 在丸激素组 (P=0.026和P=0.024,分别) 观察到疼痛感知和身体角色限制的改善.
- 没有注意到前列腺特异性抗原,血红蛋白,脂质或凝血的显著变化.
结论:
- 低剂量丸激素补充剂有效地降低了慢性稳定性 angina 的男性运动诱导的心肌缺血.
- 丸激素疗法提供了一种潜在的治疗选择,用于管理心肌痛症状并改善生活质量.
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...


